Early discharge of patients with pulmonary embolism: a two-phase observational study

157 low-risk patients with pulmonary embolism (from an initial screened cohort of 225). Exclusions included: admission for another medical reason, requirement for oxygen or additional monitoring, bleeding disorders, previous PE/further PE while on warfarin, co-existing major deep venous thrombosis, likelihood of poor compliance, significant immobility, and pregnancy.

Early discharge and outpatient management with low molecular weight heparin (tinzaparin) using existing deep venous thrombosis services.

Safety composite of deaths, bleeding, or recurrent thromboembolic events during acute treatment with low molecular weight heparin.safety